Brief: Immucell Corp Anticipates No Change To Preliminary Sales Results For Q2 2023 That Were Disclosed On July 11
07/08/2023 17:31
Aug 7 (Reuters) - ImmuCell Corp ICCC.O :
* IMMUCELL CORP - ANTICIPATES NO CHANGE TO PRELIMINARY SALES RESULTS FOR Q2 OF 2023 THAT
WERE
DISCLOSED ON JULY 11
* IMMUCELL CORP - EXPECTS TO FILE ITS QUARTERLY REPORT ON FORM 10-Q AFTER MARKET CLOSES ON
AUGUST
10
Source text for Eikon: ID:nGNX7kWTJn
Further company coverage: ICCC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ImmuCell
See all newsBrief: Immucell Announces A 46% Increase In Product Sales In Quarter Three Of 2026, Based On Preliminary, Unaudited Sales Results
ImmuCell Q2 revenue rises on higher distributor volume, price realization
Brief: ImmuCell Corporation Q2 EPS USD 0.2
ImmuCell Q2 product sales rise 11.5% on strong US demand
ImmuCell Q1 sales, profit rise on seasonal demand; to moderate mid-year